Inoue R - Search Results

1

Ki67 and BUBR1 may discriminate clinically insignificant prostate cancer in the PSA range <4 ng/ml.

Nagao K, Yamamoto Y, Hara T, Komatsu H, Inoue R, Matsuda K, Matsumoto H, Hara T, Sakano S, Baba Y, Matsuyama H. Nagao K, et al. Among authors: inoue r. Jpn J Clin Oncol. 2011 Apr;41(4):555-64. doi: 10.1093/jjco/hyq233. Epub 2011 Jan 12. Jpn J Clin Oncol. 2011. PMID: 21233104

2

Primitive neuroectodermal tumor of the spermatic cord.

Matsumoto H, Inoue R, Tsuchida M, Takahashi M, Naito K. Matsumoto H, et al. Among authors: inoue r. J Urol. 2002 Apr;167(4):1791-2. J Urol. 2002. PMID: 11912418 No abstract available.

3

Cystic embryonal sarcoma of the kidney.

Matsumoto H, Inoue R, Tsuchida M, Kawahara N, Hata J, Naito K. Matsumoto H, et al. Among authors: inoue r. J Urol. 2002 Nov;168(5):2164-5. doi: 10.1016/S0022-5347(05)64344-3. J Urol. 2002. PMID: 12394750 No abstract available.

4

Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell carcinoma.

Hirata H, Okayama N, Naito K, Inoue R, Yoshihiro S, Matsuyama H, Suehiro Y, Hamanaka Y, Hinoda Y. Hirata H, et al. Among authors: inoue r. Carcinogenesis. 2004 Dec;25(12):2379-84. doi: 10.1093/carcin/bgh254. Epub 2004 Aug 19. Carcinogenesis. 2004. PMID: 15319295

5

Identification of genes linked to gefitinib treatment in prostate cancer cell lines with or without resistance to androgen: a clue to application of gefitinib to hormone-resistant prostate cancer.

Yano S, Matsuyama H, Hirata H, Inoue R, Matsumoto H, Ohmi C, Miura K, Shirai M, Iizuka N, Naito K. Yano S, et al. Among authors: inoue r. Oncol Rep. 2006 Jun;15(6):1453-60. Oncol Rep. 2006. PMID: 16685379

6

Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy.

Sakano S, Wada T, Matsumoto H, Sugiyama S, Inoue R, Eguchi S, Ito H, Ohmi C, Matsuyama H, Naito K. Sakano S, et al. Among authors: inoue r. Br J Cancer. 2006 Sep 4;95(5):561-70. doi: 10.1038/sj.bjc.6603290. Epub 2006 Aug 1. Br J Cancer. 2006. PMID: 16880786 Free PMC article.

7

Gefitinib-related gene signature in bladder cancer cells identified by a cDNA microarray.

Inoue R, Matsuyama H, Yano S, Yamamoto Y, Iizuka N, Naito K. Inoue R, et al. Anticancer Res. 2006 Nov-Dec;26(6B):4195-202. Anticancer Res. 2006. PMID: 17201133 Free article.

8

Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer.

Yamamoto Y, Matsuyama H, Chochi Y, Okuda M, Kawauchi S, Inoue R, Furuya T, Oga A, Naito K, Sasaki K. Yamamoto Y, et al. Among authors: inoue r. Cancer Genet Cytogenet. 2007 Apr 1;174(1):42-7. doi: 10.1016/j.cancergencyto.2006.11.012. Cancer Genet Cytogenet. 2007. PMID: 17350465

9

Positive voided urine cytology predicts worse pathological findings of nephroureterectomy specimens in patients with upper tract urothelial carcinoma: does selective ureteral cytology have an additional efficacy?

Sakano S, Inamoto T, Inoue R, Matsumoto H, Nagao K, Yamamoto Y, Azuma H, Matsuyama H. Sakano S, et al. Among authors: inoue r. Jpn J Clin Oncol. 2015 Oct;45(10):968-72. doi: 10.1093/jjco/hyv114. Epub 2015 Jul 30. Jpn J Clin Oncol. 2015. PMID: 26232447

10

Factors Prognostic for Survival in Japanese Patients Treated with Sunitinib as First-line Therapy for Metastatic Clear Cell Renal Cell Cancer.

Kawai Y, Osawa T, Kobayashi K, Inoue R, Yamamoto Y, Matsumoto H, Nagao K, Hara T, Sakano S, Nagamori S, Matsuyama H. Kawai Y, et al. Among authors: inoue r. Asian Pac J Cancer Prev. 2015;16(14):5687-90. doi: 10.7314/apjcp.2015.16.14.5687. Asian Pac J Cancer Prev. 2015. PMID: 26320436 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,415 results

Search Page

Filters